On ECHEMI
Home > Drugs > Harbin Pharmaceutical Group Bioengineering Co., Ltd.
Harbin Pharmaceutical Group Bioengineering Co., Ltd.
  • Founded in:

    1995-02-20
  • Country:

    China China
  • Address:

    No. 99, Zhuhai Road, Limin Development Zone, Hulan District, Harbin
  • Tax NO.:

    91230111128024298B
  • Registered Funds:

    186.0655 million yuan
  • Website:

  • Email:

Related Drugs
Thymus alpha-sin for injection
Name Description Content CAS NO. Registered Holders
Thymalfasin

Extract from the above information

More

Extract from the above information

69440-99-9 14
Thymus alpha
Name Description Content CAS NO. Registered Holders
Thymalfasin

69440-99-9 14
Tegafur Injection
The chemical name of this product is: 1-(tetrahydro-2-furanyl)-5-fluoro-2,4(1H,3H)-pyrimidinedione. Its structural formula is: Molecular formula: C8H9FN2O3 Molecular weight: 200.17
Name Description Content CAS NO. Registered Holders
Tegafur

This product is a derivative of fluorouracil. It is activated by the liver in the body and gradually converted into fluorouracil to play an anti-tumor role. It can interfere with and block the synthesis of DNA, RNA and protein, and mainly acts on the S phase. It is a cell cycle-specific drug of the anti-pyrimidine class. Its mechanism of action, efficacy and anti-tumor spectrum are similar to those of fluorouracil, but it has a long-lasting effect, good absorption and low toxicity. The chemotherapy index is twice that of fluorouracil, and the toxicity is only 1/4 to 1/7 of that of fluorouracil. No severe bone marrow suppression was observed in the chronic toxicity test, and the effect on immunity was relatively mild.

More

This product is a derivative of fluorouracil. It is activated by the liver in the body and gradually converted into fluorouracil to play an anti-tumor role. It can interfere with and block the synthesis of DNA, RNA and protein, and mainly acts on the S phase. It is a cell cycle-specific drug of the anti-pyrimidine class. Its mechanism of action, efficacy and anti-tumor spectrum are similar to those of fluorouracil, but it has a long-lasting effect, good absorption and low toxicity. The chemotherapy index is twice that of fluorouracil, and the toxicity is only 1/4 to 1/7 of that of fluorouracil. No severe bone marrow suppression was observed in the chronic toxicity test, and the effect on immunity was relatively mild.

17902-23-7 10
Tegafur Injection
The main ingredient of this product is Tegafur. Chemical name: 1-(tetrahydro-2-furanyl)-5-fluoro-2,4(1H,3H)-pyrimidinedione. Molecular formula: C8H9FN2O3 Molecular weight: 200.17 The auxiliary material is sodium hydroxide.
Name Description Content CAS NO. Registered Holders
Tegafur

It is activated in the liver and gradually converted into fluorouracil to play an anti-tumor role. It can interfere with and block the synthesis of DNA, RNA and protein, and mainly acts in the S phase. It is a cell cycle-specific anti-pyrimidine drug. Its mechanism of action, efficacy and anti-tumor spectrum are similar to those of fluorouracil, but it has a long-lasting effect, good absorption and low toxicity. The chemotherapy index is twice that of fluorouracil, and the toxicity is only 1/4 to 1/7 of that of fluorouracil. No serious bone marrow suppression was observed in chronic toxicity tests, and the effect on immunity was relatively mild.

More

It is activated in the liver and gradually converted into fluorouracil to play an anti-tumor role. It can interfere with and block the synthesis of DNA, RNA and protein, and mainly acts in the S phase. It is a cell cycle-specific anti-pyrimidine drug. Its mechanism of action, efficacy and anti-tumor spectrum are similar to those of fluorouracil, but it has a long-lasting effect, good absorption and low toxicity. The chemotherapy index is twice that of fluorouracil, and the toxicity is only 1/4 to 1/7 of that of fluorouracil. No serious bone marrow suppression was observed in chronic toxicity tests, and the effect on immunity was relatively mild.

17902-23-7 10
Triamcinolone acetonide econazole cream
This product is a compound preparation, each gram containing 10 mg of econazole nitrate and 1.0 mg of triamcinolone acetonide.
Name Description Content CAS NO. Registered Holders
Econazole nitrate

Antifungal drugs, which have antibacterial activity against dermatophytes, molds and yeasts (such as Candida), and are also effective against some Gram-positive bacteria

More

Antifungal drugs, which have antibacterial activity against dermatophytes, molds and yeasts (such as Candida), and are also effective against some Gram-positive bacteria

10mg 68797-31-9 18
Triamcinolone acetonide

Glucocorticoids, which have anti-inflammatory, antipruritic and anti-allergic effects

More

Glucocorticoids, which have anti-inflammatory, antipruritic and anti-allergic effects

1.0mg 76-25-5 27
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.